In Vitro & In Vivo Diagnostic Substances companies

21 companies file with the SEC under industry code 2835, In Vitro & In Vivo Diagnostic Substances. The largest by market value include Idexx Laboratories Inc /DE, Lantheus Holdings, Inc. and Neogen Corp. Open a company for its income statement, balance sheet, cash flow, and SEC filings.

Idexx Laboratories Inc /DE10-Q filed Nov 2, 2026 IDXX Lantheus Holdings, Inc.10-Q filed Aug 6, 2026 LNTH Neogen Corp10-Q filed Oct 7, 2026 NEOG Celldex Therapeutics, Inc.10-Q filed Aug 6, 2026 CLDX Intellia Therapeutics, Inc.10-Q filed Aug 6, 2026 NTLA QuidelOrtho Corp10-Q filed Nov 4, 2026 QDEL Achieve Life Sciences, Inc.10-Q filed Aug 11, 2026 ACHV Myriad Genetics Inc10-Q filed Jul 31, 2026 MYGN Alpha Teknova, Inc.10-Q filed Aug 6, 2026 TKNO Anbio Biotechnology20-F/A filed Apr 9, 2026 NNNN Immucell Corp /DE/10-Q filed Aug 13, 2026 ICCC Insight Molecular Diagnostics Inc.10-Q filed Aug 10, 2026 IMDX Aspira Women's Health Inc.10-Q filed Aug 14, 2026 AWHL Biomerica Inc10-Q filed Oct 15, 2026 BMRA Volitionrx Ltd10-Q filed Aug 13, 2026 VNRX Trinity Biotech PLC20-F filed Apr 30, 2026 TRIB Cardio Diagnostics Holdings, Inc.10-Q filed Aug 7, 2026 CDIO Q/C Technologies, Inc.10-Q filed Aug 12, 2026 QCLS Nymox Pharmaceutical Corp20-F/A filed Sep 29, 2026 NYMXF Virax Biolabs Group Ltd20-F filed Jul 6, 2026 VRAX Asep Medical Holdings Inc. SEPSF

Listed largest first, by the order of the SEC's ticker file. Industry codes are the Standard Industrial Classification (SIC) codes the SEC assigns to each filer.